Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


08.10.2018

1 Am J Pathol
3 Anticancer Res
2 BJU Int
1 Clin Cancer Res
5 Eur Urol
2 Int J Oncol
2 Int J Urol
2 J Urol
1 N Engl J Med
1 Oncogene
1 Prostate
1 Urol Int
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. HUHTANIEMI R, Oksala R, Knuuttila M, Mehmood A, et al
    Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts.
    Am J Pathol. 2018 Sep 28. pii: S0002-9440(18)30499.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. HAMA Y, Kaji T
    Long-term Follow-up Results of CT-guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer.
    Anticancer Res. 2018;38:5959-5962.
    PubMed     Text format     Abstract available

  3. SUZUKI K, Sakamoto M, Terakawa T, Furukawa J, et al
    Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.
    Anticancer Res. 2018;38:5929-5935.
    PubMed     Text format     Abstract available

  4. SINHA AA, Wilson MJ
    Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
    Anticancer Res. 2018;38:5725-5732.
    PubMed     Text format     Abstract available


    BJU Int

  5. WARNER EW, Yip SM, Chi KN, Wyatt AW, et al
    DNA repair defects in prostate cancer: impact for screening, prognostication and treatment.
    BJU Int. 2018 Oct 3. doi: 10.1111/bju.14576.
    PubMed     Text format     Abstract available

  6. TORRES-ROMAN JS, Ruiz EF, Martinez-Herrera JF, Mendes Braga SF, et al
    Prostate Cancer Mortality rates in Peru and its geographic regions.
    BJU Int. 2018 Oct 3. doi: 10.1111/bju.14578.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. FLORES-MORALES A, Bergmann TB, Lavallee C, Batth TS, et al
    Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer.
    Clin Cancer Res. 2018 Oct 1. pii: 1078-0432.CCR-18-0729.
    PubMed     Text format     Abstract available


    Eur Urol

  8. OISHI M, Gill IS, Ashrafi AN, Lin-Brande M, et al
    Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up.
    Eur Urol. 2018 Sep 28. pii: S0302-2838(18)30654.
    PubMed     Text format     Abstract available

  9. GRAFF RE, Kachuri L, Witte JS
    Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement.
    Eur Urol. 2018 Sep 26. pii: S0302-2838(18)30681.
    PubMed     Text format    

  10. DEEK MP, Phillips RM, Haffner M, Tran PT, et al
    Is Androgen Deprivation Therapy "Another Deficient Therapy" for Gleason Score 9-10 Prostate Cancer?
    Eur Urol. 2018 Sep 26. pii: S0302-2838(18)30715.
    PubMed     Text format    

  11. BOEVE LMS, Hulshof MCCM, Vis AN, Zwinderman AH, et al
    Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical
    Eur Urol. 2018 Sep 25. pii: S0302-2838(18)30658.
    PubMed     Text format     Abstract available

  12. NORDSTROM T, Lindberg J, Eklund M
    Towards Next-generation Urine-based Prostate Cancer Risk Stratification.
    Eur Urol. 2018 Sep 28. pii: S0302-2838(18)30709.
    PubMed     Text format    


    Int J Oncol

  13. WU K, Na K, Chen D, Wang Y, et al
    Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.
    Int J Oncol. 2018 Sep 28. doi: 10.3892/ijo.2018.4578.
    PubMed     Text format     Abstract available

  14. TAN Y, Wang L, Du Y, Liu X, et al
    Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Int J Oncol. 2018 Sep 27. doi: 10.3892/ijo.2018.4577.
    PubMed     Text format     Abstract available


    Int J Urol

  15. YANO A, Kawakami S
    Re: Local treatment for metastatic prostate cancer: A systematic review.
    Int J Urol. 2018 Sep 30. doi: 10.1111/iju.13809.
    PubMed     Text format    

  16. AFRIANSYAH A, Hamid ARA, Mochtar CA, Umbas R, et al
    Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.
    Int J Urol. 2018 Sep 30. doi: 10.1111/iju.13813.
    PubMed     Text format     Abstract available


    J Urol

  17. AFSHARI MIRAK S, Shakeri S, Mohammadian Bajgiran A, Felker ER, et al
    3T Multiparametric MRI: Comparison of Performance With and Without Endorectal Coil for Prostate Cancer Detection, PI-RADSv2 Category and Staging with Whole Mount Histopathology Correlation in 429 Patients.
    J Urol. 2018 Sep 28. pii: S0022-5347(18)43960-2. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available

  18. BRYANT RJ, Hobbs CP, Eyre KS, Davies LC, et al
    Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study.
    J Urol. 2018 Sep 25. pii: S0022-5347(18)43943-2. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


    N Engl J Med


  19. Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380-1381.
    PubMed     Text format    


    Oncogene

  20. PAI VC, Hsu CC, Chan TS, Liao WY, et al
    ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0497.
    PubMed     Text format     Abstract available


    Prostate

  21. WADOSKY KM, Shourideh M, Goodrich DW, Koochekpour S, et al
    Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells.
    Prostate. 2018 Oct 2. doi: 10.1002/pros.23719.
    PubMed     Text format     Abstract available


    Urol Int

  22. KIM SJ, Lee SW, Ha HK
    Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Me
    Urol Int. 2018 Sep 28:1-10. doi: 10.1159/000493169.
    PubMed     Text format     Abstract available


    Urology

  23. GIANNARINI G, Girometti R, Crestani A, Rossanese M, et al
    A prospective accuracy study of Prostate Imaging Reporting and Data System version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with whole-mount pathology.
    Urology. 2018 Sep 28. pii: S0090-4295(18)31054.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: